Show simple item record

dc.contributor.authorLindsay, Colin R
dc.contributor.authorShaw, E
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorBlyth, K
dc.contributor.authorBrenton, J
dc.contributor.authorChaturvedi, A
dc.contributor.authorClarke, Noel W
dc.contributor.authorDick, C
dc.contributor.authorEvans, T
dc.contributor.authorHall, G
dc.contributor.authorHanby, A
dc.contributor.authorHarrison, D
dc.contributor.authorJohnston, S
dc.contributor.authorMason, M
dc.contributor.authorMorton, D
dc.contributor.authorNewton-Bishop, J
dc.contributor.authorNicholson, A
dc.contributor.authorOien, K
dc.contributor.authorPopat, S
dc.contributor.authorRassl, D
dc.contributor.authorSharpe, R
dc.contributor.authorTaniere, P
dc.contributor.authorWalker, I
dc.contributor.authorWallace, W
dc.contributor.authorWest, N
dc.contributor.authorButler, R
dc.contributor.authorGonzalez de Castro, D
dc.contributor.authorGriffiths, M
dc.contributor.authorJohnson, P
dc.date.accessioned2018-10-22T21:06:42Z
dc.date.available2018-10-22T21:06:42Z
dc.date.issued2018
dc.identifier.citationSomatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. 2018, 3(6): ESMO Openen
dc.identifier.issn2059-7029
dc.identifier.pmid30233821
dc.identifier.doi10.1136/esmoopen-2018-000408
dc.identifier.urihttp://hdl.handle.net/10541/621304
dc.description.abstractPhase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as facilitate an infrastructure where surplus cancer tissue could be used for research. It offered a non-trial setting to examine common UK cancer genetics in a real-world context.
dc.language.isoenen
dc.rightsArchived with thanks to ESMO openen
dc.titleSomatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalESMO Openen
html.description.abstractPhase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as facilitate an infrastructure where surplus cancer tissue could be used for research. It offered a non-trial setting to examine common UK cancer genetics in a real-world context.


Files in this item

Thumbnail
Name:
e000408.full.pdf
Size:
958.7Kb
Format:
PDF
Description:
Full text, Open Access article

This item appears in the following Collection(s)

Show simple item record